go back

Ciltacabtagene Autoleucel (Carvykti)

North Carolina rates for HCPCS C9098

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $478,630 · 10th to 90th $478,630 to $478,630
$500Kfacility $478,630

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Wellcare
Setting
Facility
Modifier
Global
Typical Low
$478,630.09
Median
$478,630.09
Typical High
$478,630.09